This comprehensive seminar explores clinical trials in multiple myeloma from three essential perspectives: the clinician, the researcher, and the clinical trials coordinator.
Haematologist Dr Wojtek Janowski provides a clear, patient-focused overview of what clinical trials are, how they are designed, and what participation involves. He explains the different phases of clinical trials, why they are critical to advancing myeloma treatment, and how patients can access trials in Australia. Dr Janowski also discusses the benefits and risks of trial participation, common misconceptions, and what to expect throughout the screening, consent, treatment, and follow-up process.
Associate Professor Kate Burberry, Deputy Chief Medical Officer at Peter MacCallum Cancer Centre, introduces the concept of teletrials. She explains how digital and remote trial models are expanding access to clinical trials for people living in regional, rural, and remote areas. Using real-world data, she demonstrates how teletrials improve equity, recruitment, and patient experience while maintaining the same safety and governance standards as traditional trials.
Finally, Lisa Fischer, Haematology Clinical Trials Coordinator at Westmead Hospital, offers an in-depth look at the role of the clinical trials nurse and coordinator. She outlines how trials are set up, how patients are supported throughout their trial journey, and what participants can expect in terms of monitoring, communication, and care.
An essential resource for myeloma patients, carers, and families seeking to better understand clinical trials, access emerging treatments, and make informed decisions about trial participation.
Keep watching
Watch our other webinars
-
Blood, bones and the tip of the iceberg: Myeloma markers and monitoring
Professor Simon Harrison provides a clear overview of how myeloma is diagnosed, monitored and assessed over time.
-
Common myeloma side effects and strategies to improve quality of life
Haematologist Joy Ho discusses common side effects of myeloma and its treatments, with practical strategies to support quality of life. The presentation covers peripheral neuropathy,…
-
Myeloma Carer’s toolkit
Myeloma Specialist Nurse Lucy Murphy shares practical guidance for people caring for someone with myeloma. She discusses the carer’s role, informed decision-making, practical support, communication,…
-
Bi-specific and tri-specific T cell engagers for the treatment of myeloma
Professor Hang Quach explains how bispecific and trispecific T-cell engagers are changing multiple myeloma treatment. He discusses how these therapies work, current and emerging treatment…
-
Travel and myeloma- National myeloma month 2022
Senior Myeloma Specialist Nurse Jo discusses travel and myeloma, including planning with your treating team, medications, medical letters, vaccinations, travel insurance, infection precautions and practical…
-
National myeloma update 2025
Prof. Miles Prince’s 2025 myeloma update: from chemo to cutting-edge immunotherapies like CAR-T & bispecifics. Learn about new treatments, access, and the future of care
-
Exploring impacts of new technology
Associate Professor Edwin Hawkins explores how myeloma cells interact with the bone marrow microenvironment and evade immune responses. Using advanced imaging and spatial transcriptomics, this…
-
Supportive care and mental health and wellbeing
Psychologist Natalie Tucky discusses mental health, supportive care, self-advocacy, and wellbeing for people living with myeloma and precursor conditions.
-
Your immune system- Supporting immune function
Learn how multiple myeloma affects the immune system, why infection risk is higher, and how treatments like immunoglobulin replacement, vaccines, and antibiotics are used to…
-
Autologous stem cell transplant
Clinical Nurse Consultant Jenny Paul explains the autologous stem cell transplant process for myeloma, covering mobilisation, chemotherapy, reinfusion, side-effect management, and long-term recovery in a…
Connect with us
Stay informed with the latest myeloma research, treatment updates, and support resources. We offer tailored newsletters for both patients and healthcare professionals with relevant information and community updates.
